Ignite Creation Date:
2025-12-24 @ 2:47 PM
Ignite Modification Date:
2026-02-23 @ 11:35 AM
Study NCT ID:
NCT06201559
Status:
COMPLETED
Last Update Posted:
2025-01-27
First Post:
2023-12-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bioequivalence Study Between Two Albendazole 400 mg Tablets in Healthy Adult Participants Under Fed Conditions
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-08-21
Start Date Type:
ACTUAL
Primary Completion Date:
2023-09-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-09-12
Completion Date Type:
ACTUAL
First Submit Date:
2023-12-30
First Submit QC Date:
None
Study First Post Date:
2024-01-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-09-11
Results First Submit QC Date:
None
Results First Post Date:
2025-01-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-17
Last Update Post Date:
2025-01-27
Last Update Post Date Type:
ACTUAL